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Objective To investigate whether randomly sampled maternal total cholesterol (TC) and triglycerides (TG) levels
during early pregnancy are associated with birth weight (BW) and postnatal growth.
Study design Data were derived from the prospective Amsterdam Born Children and their Development cohort
study. Randomly sampled TC and TG levels were determined in early gestation (median, 13; IQR, 12-14 weeks).
Outcome measures were BW SDS and weight-for-gestational age; postnatal outcome measures were SDS in
weight, length, and body mass index during the first year of life (total n = 2502).
Results The highest TG level was associated with a higher BW SDS (differences 0.20 0.06 between highest and
middle quintile; P = .002) and with a higher prevalence (13%) of an infant large for gestational age compared with
middle quintile (9%; P = .04). Infants from mothers in the lowest TG quintile had lower SDS in weight, length, and
body mass index until age 3 months, and displayed accelerated postnatal growth patterns. Maternal TC was not
associated with BW or postnatal growth.
Conclusion High maternal TG levels in the first term of pregnancy were associated with higher BWs and subse-
quently a higher occurrence of infants large for gestational age, whereas low TG levels were associated with accel-
erated postnatal growth. (J Pediatr 2011;159:736-42).
T
here is increasing evidence that maternal metabolism and intrauterine conditions affect the development and growth of
children, with consequences for their health later in life, called the fetal origins hypothesis.1-3 One of these prenatal met-
abolic factors could be the maternal lipid profile, including levels of triglycerides (TG) and total cholesterol (TC). Both
TG and TC are essential factors for optimal development of the fetus, and these 2 lipids are known to be taken up by the placenta
and metabolized and transported in various forms to the fetus.4,5 When pregnancy progresses, lipid levels increase, which sug-
gests the necessity of these metabolic changes for pregnancy maintenance and fetal growth.4 Indeed, low maternal TG and TC
levels during pregnancy are related to delayed prenatal growth and an increased risk of the infant to be born small for gestational
age (SGA).6,7 SGA may have serious health consequences later in life, such as a higher risk for premature cardiometabolic dis-
eases, for example, coronary heart disease, type 2 diabetes, and hypertension.1-3
In addition to prenatal growth, postnatal growth also may predict the development of disease later in life.3,8,9 The majority of
infants who are born SGA show an accelerated postnatal growth and rapid weight gain.9-11 This rapid weight gain contributes to
improved immunity, with a positive effect on childhood survival.9-11 However, it also is related to negative effects on health in
the long term, such as obesity and cardiovascular diseases in adulthood.12,13
Overweight and obesity, which are associated with elevated maternal TG and TC levels during pregnancy, are increasing in
the Western world. Increased maternal TG and TC levels may be associated with infants who are born large for gestational age
(LGA). Infants with LGA have an increased risk of obesity and metabolic disorders later in life.2,14 Thus, both high and low
levels of maternal TG and TC may have negative consequences for pre- and postnatal growth.
So far, most studies about pregnancy outcomes used TC and/or TG levels during the third trimester of pregnancy. It is less
clear whether TC and/or TG levels during the first trimester of pregnancy are associated with birth weight (BW). Moreover, theFrom the Departments of Public Health (T.V., S.A.) and
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This study is part of the Amsterdam Born Children and their
Development (ABCD) study. The ABCD study is a prospec-
tive community-based cohort study that examines the rela-
tionship between maternal lifestyle and psychosocial
conditions during pregnancy and the development of the
child at birth as well as in later life. Details of the study design
have been described earlier.15
In short, between January 2003 and March 2004, all preg-
nant women living in Amsterdam were invited to enroll in
the ABCD study at their first prenatal visit to an obstetric
care provider (about the 12th week of gestation). The women
were asked to complete a questionnaire that covered sociode-
mographic characteristics, medical history, lifestyle, dietary
habits (caffeine and alcohol intake, vitamin supplement
use), and psychosocial factors. The questionnaire was avail-
able in Dutch, as well as in English, Turkish, or Arabic for im-
migrant women.
Of all 12 373 invited pregnant women, 8266 returned the
pregnancy questionnaire (response rate, 67%). In the ques-
tionnaire, permission was requested to obtain growth and
development data of their infant from the youth health
care centers (YHC) in Amsterdam. In total, 6575 women
who gave birth to a live-born singleton infant gave permis-
sion to follow-up the growth data of their child. In addition,
these women were invited to participate in the ABCD bio-
marker study. For this study, an additional blood sample
was taken during routine blood collection for screening
purposes after the first prenatal checkup. In total, 4389
women (53%) participated in the ABCD biomarker study
(median, 13 weeks of gestation; IQR, 12-14 weeks). TG
and TC analyses were available for 4162 participants. Cur-
rently, 2832 women of this group had infants for whom
growth data up to 12 months of age were available; data col-
lection is still ongoing. Women who gave birth to twins, de-
livered preterm (pregnancy duration, <37 weeks), with
known diabetes (preexistent as well as pregnancy related),
or whose infants had congenital abnormalities were ex-
cluded. Women who used lipid-altering medication, such
as antiepileptic drugs, steroids, insulin, antidepressants, thy-
roid hormones, or sleep medication also were excluded.
There were no women who were using antilipidemic drugs
in our sample. The final sample included 2502 women
(Figure 1; available at www.jpeds.com). The study protocol
was approved by the medical ethics committees of all
the involved Amsterdam hospitals and the Registration
Committee of Amsterdam, and all participants gave written
informed consent.
Primary outcome variables for this study were BW and
postnatal growth until 12 months of age. BW for gestational
age SDS was determined based on sex- and parity-specific
standards from the Dutch Perinatal Registry.16 In addition
to this BW SDS as a continuous outcome variable, infants
with BW <10th percentile were classified as SGA, and those
with BW >90th percentile were LGA.The postnatal growth measurements (weight and length)
of the child were obtained from the YHC of the Public Health
Service in Amsterdam. By standard procedure, weight (g)
and length (cm) of all children in Amsterdam were measured
by trained nurses on average 12 times between age 0 and 4
years.17 In the first year of life, weight and length were mea-
sured on average 8 times. From the weight and length mea-
sures, body mass index (BMI) in kg/m2 was calculated.
Weight, length, and BMI were expressed as SDS18 by using
internal sex-specific reference curves from the ABCD study.
To further explore postnatal growth, the amount of acceler-
ated growth was calculated. Accelerated growth was defined
as an increase >0.67 SDS between 2 time points9; in the pres-
ent study, this was between 1 and 6 months of age.
Included covariables were maternal physiologic, sociode-
mographic, and behavioral characteristics, as well as infant
characteristics; these are reported to affect prenatal growth,
BW, or maternal lipid profile.9,19 Maternal variables were ob-
tained from the questionnaire, infant variables were obtained
from the YHC. Maternal physiological variables included
maternal age (years), maternal height (cm), parity (0, $1),
hypertension (no, preexistent, during pregnancy), maternal
pre-pregnancy BMI based on self-reported weight and height
(<18.5, 18.5-24.9, 25-29.9,$30 kg/m2), and weight gain (kg/
mo) in early pregnancy (first 3 months). A random imputa-
tion procedure by using linear regression analysis was used to
complete missing data on maternal weight (9.9% missing) or
maternal height (3.8% missing).20 Sociodemographic factors
included cohabitant status (living together with a partner vs
single), maternal educational attainment (years of education
after primary school (#5, 6-10, $11 years), and ethnicity
(defined by country of birth of the pregnant woman: Dutch,
Surinamese, Antillean, Turkish, Moroccan, Ghanaian, other
non-Western country, and other Western country). Behav-
ioral factors included self-reported alcohol consumption
during pregnancy (recoded into ‘‘yes’’ or ‘‘no’’), self-
reported smoking during pregnancy (recoded into ‘‘no,’’
‘‘yes,’’ and ‘‘quit smoking because of pregnancy’’), and dura-
tion of exclusive breast feeding (none, <1, 1-3, >3 months),
which was obtained from the YHC. The infant variables in-
cluded infant sex and gestational age at birth. Gestational
age at birth was based on ultrasound or, if unavailable
(<10%), on the time of the last menstrual period. Gestational
age at blood sampling was calculated with the available infor-
mation on gestational age at birth, date of birth, and date of
blood sampling.
Blood sampling was performed with participants who were
not fasting. For each participant of the biomarker study, one
blood sample was taken in a 9-mL Vacuette (Greiner BV, Al-
phen aan de Rijn, The Netherlands) for the preparation of se-
rum. The samples were sent to the Regional Laboratory
Amsterdam for processing. At the laboratory, 1-mL serum al-
iquots were prepared by centrifugation (1600g for 10minutes
at room temperature) and stored at 80C until analysis
(mean, 22 months; range, 13-29 months). TG and TC levels
in the serum samples were determined at the Laboratory for
Health Protection Research of the Dutch National Institute737
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with the glycerol-3-phosphate oxidase PAP method. TC
was assayed by using the cholesterol oxidase PAP method
on a Hitachi 912 analyzer (Roche Diagnostics, Mannheim,
Germany). The interassay coefficient of variation was 2.3%
for TGs and 1.0% for cholesterol.
Statistical Analysis
Because TG and TC levels increase with gestational age,14
both levels were corrected for gestational age at the time of
blood sampling. TG and TC levels were divided into quintiles
for comparison. A descriptive analysis of TG and TC levels,
outcome variables, and maternal and infant characteristics
was performed by using Pearson c2 analysis for categorical
variables and analysis of variance for continuous variables.
Subsequently, univariate (unadjusted) associations between
TG and TC levels and BW SDS were explored by using regres-
sion analysis, followed bymultivariate analyses in which a pri-
ori stated confounders were added to the model (maternal
age, maternal height, hypertension, maternal pre-pregnancy
BMI, weight gain during early pregnancy, ethnicity, smoking,
alcohol use, education level, and cohabitant status).
Associations between different TG and TC quintiles and
postnatal growth patterns (weight, length, and BMI expressed
as SDS) in the first year of life were explored by linear regres-
sion analyses. For this, the general mixed model was used, be-
cause this procedure allows for multiple time points of
measurements, individual differences in intervals between
measurements, and a different number of measurements per
individual. To take into account possible confounders, besides
a univariate analysis, amultivariablemodelwas created. In this
multivariable model, a priori stated confounders and their in-
teraction terms with infants’ age were added (maternal age,
maternal height, parity, maternal pre-pregnancy BMI, weight
gain during early pregnancy, ethnicity, education level, cohab-
itant status, smoking, alcohol use, pregnancy duration, and
BW). To compare SDS trajectories between the TG and TC
quintiles in more detail, post hoc comparisons were done at
multiple time points: 1, 3, 6, 9, and 12 months. The amount
of accelerated growth in the different quintiles was determined
by using the Pearson c2 analysis. In all analyses, a P value <.05
was considered significant. Analyses were performed with the
SPSS package version 16.0 (SPSS Inc, Chicago, Illinois).
Results
The women in the present study had a mean (SD) age of 31.0
 4.8 years; 56.4% were primiparous and 67.7% were of
Dutch origin (Table I). Mean (SD) BW was 3512  489 g
and mean gestational age was 40.1 weeks. Compared with
mothers who completed the questionnaire but were not
included in this study (no blood sample or growth data; n
= 4449), the included mothers were significantly older and
taller, had a higher education, had a lower BMI, and were
more likely to consume alcohol. The mothers included in
the study also were more often primiparous, of Dutch
origin, and less often living alone.738Women who were relatively shorter, with higher parity,
higher pre-pregnancy BMI, higher early weight gain, hyper-
tension, lower education; women who smoked and had no al-
cohol consumption during pregnancy; and women with
shorter pregnancy duration had significantly higher stan-
dardized maternal TG levels as shown in Table I. Women
of younger age who were relatively taller had lower TC
levels. However, women with pregnancy-related
hypertension, higher pre-pregnancy BMI, more weight gain
during early pregnancy, and women who smoked and did
not breast feed had significantly higher TC levels.
In the univariate analysis maternal TG was positively asso-
ciated with BW SDS (Table II). Mothers with low TG levels
gave birth to infants with lower BW SDS, and mothers with
higher TG levels gave birth to infants with higher BW SDS.
Mothers with the highest TG levels (Q5) gave birth to
infants with significantly higher BW SDS than mothers in
the middle quintile (mean estimated difference 0.20 
0.06). Correspondingly, women with the highest TG level
(Q5) gave birth to a significantly higher percentage of
infants born LGA (12.9%) than women in the middle TG
quintile (9.1%; P = .04) (Figure 2). Although infants with
BWs <2500 g showed lower TC values compared with
infants with higher BWs (Table I), TC levels were not
associated with BW SDS or with SGA or LGA (Table II,
Figure 2).
The SDS trajectories forweight, length, andBMI for the dif-
ferent quintiles of maternal TG and TC at the first trimester of
gestation are shown in Figure 3. Multivariate analysis showed
significantly different growth patterns over time for SDS of
weight (P = .002). The growth patterns of infants born of
women with the lowest TG levels (Q1) deviated more from
their individual growth line than the growth patterns of
other infants; that is, they started with a relatively low BW,
but their weight progressively increased during the first year
toward levels close to those of the other infants. Post hoc
analyses showed that differences in weight among TG
quintiles were only significant at 1 month; these differences
were 0.140 SDS for Q1 vs Q5, and 0.139 SDS for Q1 vs Q3.
For length, the individual average lines with SDS did not
differ significantly among subsequent TG quintiles,
although there was a tendency for the Q1 pattern to deviate
(P = .061). Post hoc analyses revealed significant differences
at 1 month only for Q1 vs Q5 (0.140). For BMI, a similar
tendency was observed for Q1, with a relatively low BMI at
1 month and a relatively high BMI at 12 months.
Differences were present at the first month after birth only
for Q1 vs Q3 (0.129).
To further explore the deviant growth pattern for infants
born to mothers with the lowest TG levels (Q1), the level
of accelerated weight gain (increase of SDS weight >0.67)
of Q1 was compared with the other TG quintiles. The per-
centage of infants in Q1 that showed accelerated growth
(24.5%) during the first 6 months of life was significantly
higher compared with the other TG quintiles (mean,
19.6%; P = .027). Although both length and BMI showed
a similar tendency with regard to an accelerated growth, noVrijkotte et al
Table I. Maternal and infant characteristics and their association with maternal TG and TC level
n (%) TG level, mean (SD), (mmol/L)*† TC level, mean (SD), (mmol/L)*†
Maternal age (y)
<25 367 (14.7) 1.29  0.53 4.79  0.80z
25-35 (reference) 1737 (69.4) 1.32  0.55 4.99  0.88
>35 398 (15.9) 1.37  0.53 5.01  0.81
Maternal height (cm)
<166 810 (32.4) 1.39  0.56{ 4.95  0.89
166-172 (reference) 890 (35.6) 1.31  0.54 5.02  0.84
>172 802 (32.0) 1.27  0.51 4.92  0.86x
Parity
0 1412 (56.4) 1.28  0.50z 4.99  0.84
$1 1090 (43.6) 1.37  0.59 4.94  0.89
Hypertension
No (reference) 2217 (88.6) 1.30  0.52 4.95  0.86
During pregnancy 212 (8.5) 1.50  0.68z 5.15  0.77z
Preexistent 73 (2.9) 1.48  0.70{ 5.03  1.05
Maternal pre-pregnancy BMI (kg/m2)
<18.5 115 (4.6) 1.27  0.43 4.81  0.78
18.5-24.9 (reference) 1869 (74.7) 1.28  0.53 4.95  0.85
25.0-29.9 388 (15.5) 1.46  0.60z 5.08  0.90x
$30.0 130 (5.2) 1.50  0.59z 5.05  0.95
Weight gain during early pregnancy (kg/mo)
<0.3 437 (17.8) 1.32  0.57 4.89  0.80
0.3-1.0 (reference) 1125 (45.9) 1.29  0.51 4.95  0.86
>1.0 890 (36.3) 1.36  0.57{ 5.05  0.88x
Education (y after primary school)
0-5 625 (25.2) 1.40  0.61z 4.93  0.93
6-10 1031 (41.5) 1.32  0.56x 4.98  0.85
>10 (reference) 826 (33.3) 1.26  0.46 4.97  0.81
Cohabitant status
Single 272 (10.9) 1.29  0.52 4.94  0.91
Partner 2224 (89.1) 1.33  0.55 4.97  0.86
Time at blood withdrawal
8:00 a.m. to 1:00 p.m. (reference) 1147 (64.4) 1.40  0.55 5.14  0.93
1:00-3:00 p.m. 343 (19.2) 1.53  0.67{ 5.05  0.87
After 3:00 p.m. 292 (16.4) 1.37  0.59 5.10  0.87
Ethnicity
Dutch (reference) 1695 (67.7) 1.31  0.53 5.00  0.84
Surinamese 102 (4.1) 1.40  0.56 4.88  0.87
Antillean 25 (1.0) 1.09  0.46x 4.74  0.90
Turkish 92 (3.7) 1.47  0.67{ 4.95  0.93
Moroccan 144 (5.8) 1.37  0.52 4.87  0.90
Ghanaian 29 (1.2) 0.98  0.32{ 4.56  0.81{
Other non-Western country 190 (7.5) 1.40  0.65x 4.77  0.86z
Other Western country 225 (9.0) 1.26  0.44 5.07  0.95
Alcohol use while pregnant
No 1881 (75.2) 1.34  0.56 4.96  0.88
Yes 620 (24.8) 1.25  0.49z 4.50  0.82
Smoking while pregnant
No (reference) 1830 (75.0) 1.30  0.52 4.95  0.85
Quit smoking 383 (15.7) 1.29  0.52 4.99  0.84
Yes 227 (9.3) 1.52  0.69z 5.09  0.89x
Infant sex
Male 1196 (47.8) 1.32  0.52 4.95  0.84
Female 1306 (52.2) 1.32  0.56 4.99  0.88
Duration of pregnancy (wk)
37-40 1779 (71.6) 1.34  0.56 4.98  0.86
41-43 707 (28.4) 1.27  0.50z 4.94  0.86
Mean birth weight (g)
<2500 41 (1.6) 1.21  0.56 4.63  0.79x
2500-4000 (reference) 2069 (82.9) 1.31  0.53 4.97  0.86
>4000 385 (15.5) 1.40  0.62{ 5.01  0.89
Duration of breast feeding
None 390 (16.0) 1.32  052 5.08  0.83z
<1 mo 300 (12.3) 1.32  0.52 4.94  0.89
1-3 mo 760 (31.2) 1.32  0.55 5.00  0.84x
>3 mo (reference) 986 (40.5) 1.32  0.56 4.91  0.88
*TG and TC levels were standardized for gestational age at blood sampling.
†Significantly different from the reference group or other group.
zP # .001.
xP # .05.
{P # .01.
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Table II. Univariate and multivariate associations
between maternal TG and TC and standardized birth
weight
Mean (SD) (mmol/L) Univariate, b (SE)† Model 1, b (SE)*†
TG
Q1 0.73  0.14 0.03  0.07 0.06  0.06
Q2 1.01  0.06 0.03  0.07 0.00  0.06
Q3 1.23  0.06 Reference Reference
Q4 1.49  0.10 0.04  0.07 0.03  0.06
Q5 2.15  0.52 0.17  0.07z 0.20  0.06x
TC
Q1 3.87  0.33 0.12  0.07 0.09  0.06
Q2 4.48  0.13 0.07  0.07 0.09  0.06
Q3 4.89  0.12 Reference Reference
Q4 5.36  0.15 0.07  0.07 0.08  0.06
Q5 6.23  0.61 0.11  0.07 0.11  0.06
*Model 1, adjusted for maternal age, maternal height, maternal pre-pregnancy BMI, ethnicity,
education level, cohabitant status, smoking, and alcohol use.
†Significantly different from the reference group.
zP # .05.
xP # .01.
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Figure 2. Weight for gestational age according to TG and TC
quintiles. Differences between TG quintiles: %SGA (P = .768),
%LGA (P = .032); between TC quintiles: %SGA (P = .098), %
LGA (P = .601).
THE JOURNAL OF PEDIATRICS  www.jpeds.com Vol. 159, No. 5significant differences between Q1 and other TG quintiles
were found. No associations were found between TC quin-
tiles and weight, length, and BMI trajectories (overall pattern
and no post hoc differences).
Discussion
This large, community-based cohort study showed thatmater-
nal TG levels in early pregnancy were associated with BW and
postnatal growth. Mothers with high TG levels had infants
with high BWs, reflected in weight for gestational age. Signif-
icantly more infants frommothers who belonged to the high-
est quintile were born LGA. However, low TG levels were
associated with an altered growth pattern after birth. TC levels
were not associated with BW, weight for gestational age, or
postnatal growth. These findings suggest thatmaternal TG sta-
tus in the first trimestermay be a factor to consider in fetal and
neonatal growth, and in matters related to public health.
Our results are in line with other researchers who reported
positive associations between TG levels and BW but not be-
tween TC levels and BW.21,22 Edison et al7 reported that TC
levels less than their third population percentile were associ-
ated with low BW. The fact that their mean TC level of the
third population percentile was lower than ourmean TC level
of the first quintile (3.6 mmol/L vs 3.9 mmol/L) explains the
incongruent results. It might be that only very low maternal
TC levels are related to low BW.
Furthermore, maternal TG in the highest levels (>75th per-
centile) is reported to be a significant predictor of LGA.22 All
these latter studies used fasting TG serum concentrations de-
termined in the third trimester (24-32 weeks). In contrast, we
used nonfasting serum TG levels determined early in preg-
nancy (median gestational age, 13 weeks). Only one other
study used nonfasting serum TG levels determined early in
pregnancy23; in that study (as in ours), TG correlated posi-
tively with BW in all their subjects (n = 338).
Although associations between maternal TG and TC levels
and BW have been reported, to our knowledge, ours is the740first study to investigate maternal TG and TC levels and post-
natal growth. We found differences in postnatal growth pat-
terns for different TG quintiles but not for different TC
quintiles. Although the differences were significant only up
to 3 months after birth, the patterns suggest an accelerated
growth for infants born to mothers with a low TG, which al-
lows those infants with growth restriction to catch up with
their peers within the first year of life. For weight, accelerated
growth was indeed observed: infants from the lowest quintile
showed significantly more accelerated weight gain (>0.67
SDS) between 1 and 6months compared with the other quin-
tiles. The same pattern was observed for length, although not
significant, and this supports the hypothesis that these infants
catch up in weight and length in early infancy to reach their
genetic growth trajectory.24 The BMI pattern showed a de-
crease in those infant of mothers with high TG levels, which
may suggest that when the fetal growth-enhancing properties
of TG are taken away at birth, infants gain adiposity less rap-
idly. Further studies are needed to examine which specific
factors (eg, perhaps hormones and nutrition) influence these
accelerated growth patterns and whether accelerated gain in
weight in accordance with length results in a favorable
body composition in terms of less adiposity at adult age.
Low BW in combination with accelerated growth is
a known risk factor for cardiovascular diseases and type 2 di-
abetes.10,12,13 Therefore, infants born from mothers with
a low TG level might be at higher risk to develop cardiovas-
cular diseases; however, this hypothesis needs to be con-
firmed. Moreover, these infants should be followed up into
adulthood to establish whether or not any of these unfavor-
able effects of low BW and catch-up growth actually occur.
The underlying mechanisms of the associations between
maternal TG level and prenatal and postnatal growth are
not yet fully understood. Transplacental transfer of free fatty
acids is important for the supply of components for fetal de-
velopment. Maternal TGs are lipolysed in the placenta to free
fatty acids by endothelial-placental lipase, and maternal TG
levels (but not maternal insulin levels) regulate the presenceVrijkotte et al
Figure 3. Infant SDSweight, SDS length, and SDSBMI as a function of age for the different TG and TC quintiles. Based onmixed
models and adjusted formaternal age, maternal height, parity, maternal pre-pregnancy BMI, weight gain during early pregnancy,
ethnicity, education level, cohabitant status, smoking, alcohol use, pregnancy duration, and birth weight. Bars represent SEM.
Asterisks mean difference between Q3-Q1 and Q5-Q1 for weight, Q5-Q1 for length, and Q3-Q1 for BMI.
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When the expression of these enzymes in the placenta is dis-
rupted, intrauterine growth restriction occurs.25 Deficiencies
or mutations may give rise to shifts in maternal TG metabo-
lism, although it is unknown how such defects will affect pla-
cental and/or fetal metabolism.26 However, it should be
noted that our TG levels are determined in the first trimester
of pregnancy and that these enzymatic imbalances play a role
in the last trimester. Future translational studies should in-
vestigate other potential mechanisms that might explain
our observations. Because maternal TG will influence fetal
metabolism, it is likely that this will affect fetal and neonatalMaternal Triglyceride Levels during Early Pregnancy are Associatfat mass. Indeed, TG was previously found to be strongly cor-
related with neonatal fat mass (abdominal circumference).27
Therefore, in addition to BW and BMI, neonatal fat mass
should be taken into consideration in future research.
Finally, the present study has some limitations and
strengths. Despite the large sample size, some selective par-
ticipation occurred. Due to the exclusion criteria, our re-
sults apply to a relatively healthy sample. Furthermore,
blood sampling was performed randomly in a nonfasting
state, which will affect TG, and was performed on only
one occasion. Repeating the analysis with time at blood
withdrawal into the models for TG did not change theed with Birth Weight and Postnatal Growth 741
THE JOURNAL OF PEDIATRICS  www.jpeds.com Vol. 159, No. 5results (data not shown). We think that the nonfasting state
probably only slightly diluted our results. Lifestyle and
maternal characteristics were self-reported, which may
have introduced bias for some measures (such as BMI), if
the women misreported. In large epidemiologic studies,
self-report has been found to accurately measure BMI,28
however, we cannot rule out some residual confounding.
Our data on the exact amount of breast feeding also were
limited. Breast feeding is known to be an important factor
that influences infant growth, including catch-up growth.9
In future studies, the relation between lipid concentrations
in breast milk and infant growth could be investigated. The
lipid concentration in breast milk could give some indica-
tion as to whether infant growth is mainly affected by feed-
ing after birth or is determined intrauterine.
The present study suggests that both enhanced and
reduced maternal TG levels in the first trimester of preg-
nancy significantly contribute to fetal growth and postnatal
adaptive growth by acceleration of newborns’ growth. Our
results suggest that more knowledge is needed to define
optimal maternal TG ranges during pregnancy and that
these efforts could benefit when counseling women with
dyslipidemia. n
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Amsterdam’s pregnant women  
N= 12 373  
Questionnaire to pregnant woman
N= 8266
Live born infants and permission to follow up   
N= 6575  
Biomarker study: TC/TG available   
N= 4162  
TC/TG + Growth data until 12 months  
N= 2832  
Sample  
N= 2502  
Exclusion:  
- Twins (n=26)   
- Preterm (n=162)   
- Diabetes (pre-existent as well as  
gestational diabetes (n=27)  
- Antiepileptic drug users (n=5)  
- Steroid users (n=13)   
- Insulin users (n=16)  
- Antilipidemic drug  users (n=0)  
- Antidepressant users (n=35)  
- Thyroid hormone users (n=27)  
- Sleep medication users (n=37)  
- Con g enital abnormalities  ( n=50 )
Figure 1. Schematic presentation of the study with all ex-
clusion criteria.
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